Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Miyamoto

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Radiation Oncology (London, England)|December 14, 2019
The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapyYasuhiro Dekura, Kentaro Nishioka, Takayuki Hashimoto, et al.
Radiation Oncology (London, England)|March 19, 2013
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapyChie Toramatsu, Norio Katoh, Shinichi Shimizu, et al.
Cancer Science|January 12, 2013
Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinaseYoshiko Awazu, Akio Mizutani, Yoshinori Nagase, et al.
Medical Physics|December 21, 2023
Technical note: Application of an optical hydrophone to ionoacoustic range detection in a tissue-mimicking agar phantomShota Sueyasu, Koki Kasamatsu, Taisuke Takayanagi, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitorNaoki Miyamoto, Nozomu Sakai, Takaharu Hirayama, et al.
Medical Physics|July 5, 2013
Integration of a real-time tumor monitoring system into gated proton spot-scanning beam therapy: an initial phantom study using patient tumor trajectory dataTaeko Matsuura, Naoki Miyamoto, Shinichi Shimizu, et al.
Medical Physics|September 11, 2012
Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation studyTaeko Matsuura, Kenichiro Maeda, Kenneth Sutherland, et al.
Clinical and Translational Radiation Oncology|January 23, 2023
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancerYusuke Uchinami, Takahiro Kanehira, Yoshihiro Fujita, et al.
Clinical and Translational Radiation Oncology|May 31, 2022
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicityYusuke Uchinami, Norio Katoh, Ryusuke Suzuki, et al.
Surgical Case Reports|July 7, 2022
Axillary lymphangioma that developed following COVID-19 vaccination: a case reportSoichiro Sasa, Hiroaki Inoue, Tomohiro Inui, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Radiation Oncology (London, England)|December 14, 2019
The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapyYasuhiro Dekura, Kentaro Nishioka, Takayuki Hashimoto, et al.
Radiation Oncology (London, England)|March 19, 2013
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapyChie Toramatsu, Norio Katoh, Shinichi Shimizu, et al.
Cancer Science|January 12, 2013
Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinaseYoshiko Awazu, Akio Mizutani, Yoshinori Nagase, et al.
Medical Physics|December 21, 2023
Technical note: Application of an optical hydrophone to ionoacoustic range detection in a tissue-mimicking agar phantomShota Sueyasu, Koki Kasamatsu, Taisuke Takayanagi, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitorNaoki Miyamoto, Nozomu Sakai, Takaharu Hirayama, et al.
Medical Physics|July 5, 2013
Integration of a real-time tumor monitoring system into gated proton spot-scanning beam therapy: an initial phantom study using patient tumor trajectory dataTaeko Matsuura, Naoki Miyamoto, Shinichi Shimizu, et al.
Medical Physics|September 11, 2012
Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation studyTaeko Matsuura, Kenichiro Maeda, Kenneth Sutherland, et al.
Clinical and Translational Radiation Oncology|January 23, 2023
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancerYusuke Uchinami, Takahiro Kanehira, Yoshihiro Fujita, et al.
Clinical and Translational Radiation Oncology|May 31, 2022
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicityYusuke Uchinami, Norio Katoh, Ryusuke Suzuki, et al.
Surgical Case Reports|July 7, 2022
Axillary lymphangioma that developed following COVID-19 vaccination: a case reportSoichiro Sasa, Hiroaki Inoue, Tomohiro Inui, et al.
Pageof 14